HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 134 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2014. The put-call ratio across all filers is 1.16 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,612,726 | +65.9% | 173,108 | +56.7% | 0.04% | +75.0% |
| Q2 2023 | $3,985,014 | -21.7% | 110,480 | -17.1% | 0.02% | -28.6% |
| Q1 2023 | $5,087,214 | -15.3% | 133,208 | +26.2% | 0.03% | -20.0% |
| Q4 2022 | $6,005,169 | +263.7% | 105,539 | +181.3% | 0.04% | +250.0% |
| Q2 2022 | $1,651,000 | +624.1% | 37,513 | +603.5% | 0.01% | +900.0% |
| Q4 2020 | $228,000 | +53.0% | 5,332 | -54.1% | 0.00% | 0.0% |
| Q2 2017 | $149,000 | -47.2% | 11,625 | -42.2% | 0.00% | -50.0% |
| Q1 2014 | $282,000 | – | 20,110 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |